New drug tested for bulging eyes condition
NCT ID NCT06557850
Summary
This study follows up with patients who received an experimental drug called Lu AG22515 for moderate-to-severe Thyroid Eye Disease. The main goal is to see if the treatment continues to reduce eye bulging over time. Researchers are tracking 20 adults to monitor the drug's long-term effects and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diagnostic-Consultative Center Alexandrovska
Sofia, 1431, Bulgaria
-
Jagiellonian University Medical College
Krakow, Lesser Poland Voivodeship, 30-688, Poland
-
Uniewrsyteckie Centru Kliniczne
Katowice, 40-514, Poland
-
UnivCentrum Zdrowia MDM EB GROUP Sp.zo.o
Warsaw, 00-189, Poland
-
University Clinical Center of The Republic Of Srpska
Banja Luka, Republika Srpska, 78000, Bosnia and Herzegovina
-
University Specialized Hospital for Active Treatment in Endocrinology (USHATE) "Acad. Ivan Penchev"
Sofia, 1431, Bulgaria
Conditions
Explore the condition pages connected to this study.